Vinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.xVinaora Nivo Slider 3.x
Management of Asthma

  • Knowledge Translation in Health Care: from evidence to practice
  • Emergency Approach to Asthma Attacks in adults & children
  • Fixed airflow obstruction in Asthma: pathological basis and consequences for treatment
  • The role of infection in Asthma exacerbations
  • Occupational Asthma
  • Asthma and obesity: what is the relationship?
  • Management of asthma in pregnancy
  • Endotyping Asthma
  • Airways Remodeling and Pulmonary Function Decline
  • Modulation of Airways Remodeling as Target of Treatment
  • Asthma Awareness at first step of right management
  • Modern Technologies to implement Asthma Management
  • Different Treatment Strategies for Asthma Control
  • Asthma: a disease of many phenotypes
  • Asthma in the elderly


Asthma & COPD


  • The Path to Precision Medicine in COPD
  • New COPD Treatments
  • Tobacco smoking & Asthma
  • Adherence to Treatment in Allergy, Asthma & COPD: a neglected issue
  • Smoking Cessation – Essential part of asthma treatment
  • The Path to Personalized Medicine in Asthma
  • Patient Stratification and proper Treatment


Enviroment & Asthma


  • Climate Change & Allergic Asthma
  • Biodiversity and allergic disease
  • The added value of CRD-Component Resolved Diagnosis in Respiratory Allergy
  • Probiotics and Asthma
  • The changing microbiome and allergy
  • OMICS: a step forward in understanding Asthma


New Treatments on Asthma


  • AIT-Allergen ImmunoTherapy in Asthma: emerging evidences
  • Monoclonal antibodies on Asthma Treatment
  • Biomarkers of treatment responses
  • Thermoplasty and Asthma Treatment: new evidences


Primary Health Care and Asthma


  • Basic principles of guidelines implementation
  • Translation of GINA strategy into care
  • How to address care gaps in primary care
  • A Novel paradigm for generating relevant evidence for guidelines: real life trials
  • COPD Treatments as future Asthma Treatment
  • Integrated Care Pathways in Obstructive Bronchial Diseases
  • Inhaled corticosteroids: different mechanisms and efficacy in Asthma and COPD


Severe Asthma


  • Genetic factors and epigenetics
  • Pharmacogenetics in deciding treatment options
  • How does epithelial integrity protect against environmental insults
  • Severe Asthma: a different phenotype or different phenotypes?
  • New biologic agents for treating severe Asthma
  • Clusters and biomarkers of severe asthma in adults
  • LAMA in Asthma: only for patients with severe poorly reversible airflow obstruction?


Upper airways and Asthma


  • Breakdown in epithelial protection in Rhinosinusitis
  • Links between asthma and rhinitis
  • Upper airway influences on lower airways
  • Chronic rhinosinusitis and asthma in childhood
  • Predictive risk of rhinitis for asthma in children
  • Severe Paediatric asthma

Dates to remember


All abstracts should be submitted by

December 18, 2015

Preliminary program

August 20, 2015

Early Registration deadline

October 30, 2015

Late-breaking abstract submission

January 7, 2016

Middle registration deadline

January 15, 2016

Cancellations with refund deadline

January 15, 2016

E-poster submission deadline

February 15, 2016

Exhibition set up

March 11, 2016

Congress dates

March 12-15, 2016

CME Credits Publication

April 1, 2016

WCA-2016 app


The WCA-2016 app is now available for Android and iOS devices. Download it to obtain your personal discount code and register for the Congress at reduced fees